Arizona State Retirement System Raises Position in Celgene Corporation (CELG)

Cornelia Mascio
Ottobre 12, 2017

Acropolis Investment Management LLC bought a new stake in shares of Celgene Corporation during the second quarter valued at approximately $144,000. The stock has a market cap of $91.18 billion, a price-to-earnings ratio of 43.85 and a beta of 1.74. About 3.10 million shares traded. NEXT plc (LON:NXT) has 0.00% since October 12, 2016 and is. It has underperformed by 3.35% the S&P500.

Moneta Group Investment Advisors Llc increased Celgene Corp Com (CELG) stake by 207.49% reported in 2017Q2 SEC filing. Osborn Rohs Williams & Donohoe Ltd claims 24,095 shares worth $3,514,000. It was reported on Oct, 11 by Barchart.com. The institutional investor owned 453,335 shares of the biopharmaceutical company's stock after acquiring an additional 45,448 shares during the period. About 1.72M shares traded. It has outperformed by 0.30% the S&P500.

Investors sentiment increased to 1.34 in 2017 Q2. Its down 0.39, from 1.41 in 2017Q1. Pioneer Investment Management Inc. raised its position in Celgene Corporation by 15.7% in the first quarter. 602.51 million shares or 1.81% more from 591.78 million shares in 2017Q1 were reported. Mitsubishi Ufj And Bk Corporation invested in 0.45% or 1.78 million shares. The Massachusetts-based Grimes And has invested 0.02% in Celgene Corporation (NASDAQ:CELG). The shares were sold at an average price of $134.52, for a total transaction of $1,008,900.00. Winslow Evans Crocker has invested 0% in Celgene Corporation (NASDAQ:CELG).

Ltd bought 4,850 shares during the last quarter increasing its stake in Celgene Corporation (CELG) by 2.0%. Adirondack Trust Co.'s holdings in Celgene Corporation were worth $584,000 at the end of the most recent quarter. Tci Wealth Advsr holds 0.2% or 3,043 shares. Ltd. increased its position in shares of Celgene Corporation by 47.5% during the first quarter. Bb Biotech Ag holds 12.9% or 3.25M shares in its portfolio. Dubuque Commercial Bank And Tru owns 1.4% invested in Celgene Corporation (NASDAQ:CELG) for 49,367 shares. Sg Americas Secs Limited Liability Com owns 0% invested in Celgene Corporation (NASDAQ:CELG) for 3,622 shares. Eventide Asset Management Ltd Liability Corp has invested 2.47% in Celgene Corporation (NASDAQ:CELG). Ltd. now owns 1,180 shares of the biopharmaceutical company's stock worth $147,000 after purchasing an additional 380 shares in the last quarter. As of the end of the quarter Eqis Capital Management, Inc. had acquired a total of 5,685 shares growing its stake by 16.5%.

Since June 15, 2017, it had 0 buys, and 3 insider sales for $2.36 million activity. On Saturday, June 17 the insider CASEY MICHAEL D sold $1.16 million. 8,577 shares were sold by Huber Reid M, worth $1.02 million. Therefore 85% are positive. E&G Advsrs LP owns 0.86% invested in Celgene Corporation (NASDAQ:CELG) for 13,718 shares. The firm has "Buy" rating by Stifel Nicolaus given on Thursday, July 6. Jefferies initiated the shares of CELG in report on Wednesday, September 9 with "Buy" rating. The company was maintained on Friday, July 28 by Leerink Swann. The rating was maintained by Cantor Fitzgerald with "Buy" on Tuesday, August 22. The firm has "Buy" rating by Mizuho given on Wednesday, July 26. The stock of NEXT plc (LON:NXT) earned "Hold" rating by Societe Generale on Friday, September 11. The stock of Celgene Corporation (NASDAQ:CELG) has "Buy" rating given on Friday, November 6 by Canaccord Genuity. BMO Capital Markets reissued an "outperform" rating and set a $160.00 price objective (up previously from $152.00) on shares of Celgene Corporation in a report on Friday, July 28th. Equities analysts expect that Celgene Corporation will post $7.32 EPS for the current fiscal year. CELG's profit will be $1.35B for 20.27 P/E if the $1.72 EPS becomes a reality.

08/28/2017 - Celgene Corporation had its "neutral" rating reiterated by analysts at BTIG Research.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Fool.com which released: "Better Buy: Celgene Corporation vs. Merck & Co., Inc." on September 22, 2017, also Businesswire.com with their article: "Celgene Corporation to Announce Third Quarter 2017 Results on October 26, 2017 ..." published on October 02, 2017, Seekingalpha.com published: "Celgene Offers High Growth At An Inexpensive Price" on September 11, 2017. Oakworth Capital Inc. grew its holdings in shares of Celgene Corporation by 11.7% during the 2nd quarter.

Several research analysts have weighed in on the stock. After $-0.23 actual EPS reported by Pieris Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -13.04% EPS growth.

Investors sentiment decreased to 1.02 in Q2 2017. Its down 0.01, from 0.79 in 2017Q1. Adell Harriman & Carpenter stated it has 28,244 shares. Investec Asset Mgmt Ltd accumulated 1.56 million shares or 0.96% of the stock. Next Financial Grp Inc holds 0% or 5,491 shares. Brighton Jones Lc owns 7,797 shares or 0.14% of their United States portfolio. Tokio Marine Asset Management reported 0.3% of its portfolio in E I Du Pont De Nemours And Co (NYSE:DD). California State Teachers Retirement holds 0.08% or 309,984 shares in its portfolio. The stock declined 1.29% or $1.48 reaching $113.29 on the news. Vident Advisory Limited reported 8,568 shares. Heritage Investors Mgmt accumulated 18,350 shares or 0.16% of the stock. Citigroup Inc (NYSE:C) was raised too. Highstreet Asset Mngmt has invested 0.22% in Celgene Corporation (NASDAQ:CELG). Kingdom Ridge holds 0.26% or 25,100 shares. The company was maintained on Wednesday, October 4 by Jefferies. Du Pont had 52 analyst reports since July 30, 2015 according to SRatingsIntel. On October 5, 2017 the stock rating was rated "Underweight" by Morgan Stanley a cut from the previous "Equal-weight" rating. The stock has "Sector Perform" rating by RBC Capital Markets on Wednesday, July 29.

05/17/2017 - Celgene Corporation had its "sell" rating reiterated by analysts at Goldman Sachs.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE